NovoCure Ltd. (NVCR)
12.53
+2.03
(+19.33%)
USD |
NASDAQ |
Feb 12, 16:00
12.44
-0.09
(-0.72%)
After-Hours: 07:47
NovoCure Free Cash Flow : -65.17M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LivaNova Plc | 191.43M |
| Abbott Laboratories | 6.917B |
| Accuray, Inc. | 11.11M |
| Alphatec Holdings, Inc. | -3.35M |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 20.57M |
| Cash from Investing (Quarterly) | 71.44M |
| Cash from Financing (Quarterly) | 100.52M |
| Free Cash Flow Per Share (Quarterly) | 0.1333 |
| Free Cash Flow to Equity (Quarterly) | -82.77M |
| Free Cash Flow to Firm (Quarterly) | 14.92M |
| Free Cash Flow Yield | -4.70% |